Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US FDA Slams Zydus For Flawed Investigation, ‘Unofficial’ Books

This article was originally published in PharmAsia News

Executive Summary

A US FDA warning letter against Zydus Cadila's Indian sites contains some sharp references to the firm's flawed investigations into warfarin tablet failures, controls over computerized systems and poor documentation practices.



Related Companies